Texas Dermatology and Laser Specialists Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2016
NCT02024581
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

east indian sandalwood oil (1 trial)

san007 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Molluscum Contagiosum (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2